LEADER 02476nam 2200625 a 450 001 9911018954203321 005 20200520144314.0 010 $a9786613679086 010 $a9781280768316 010 $a1280768312 010 $a9780470718766 010 $a0470718765 010 $a9780470716137 010 $a0470716134 035 $a(CKB)1000000000687628 035 $a(EBL)703723 035 $a(OCoLC)775867033 035 $a(SSID)ssj0000715088 035 $a(PQKBManifestationID)11377546 035 $a(PQKBTitleCode)TC0000715088 035 $a(PQKBWorkID)10701236 035 $a(PQKB)10090050 035 $a(MiAaPQ)EBC703723 035 $a(Perlego)2763218 035 $a(EXLCZ)991000000000687628 100 $a20120305d1951 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 12$aA Ciba Foundation symposium $eliver disease /$fconsulting editor, Sheila Sherlock ; editor for the Ciba Foundation, G.E.W. Wolstenholme 210 $aLondon $cJ. & A. Churchill Ltd.$d1951 215 $a1 online resource (298 p.) 225 1 $aNovartis Foundation Symposia ;$vv.823 300 $a"With 112 illustrations." 311 08$a9780470722190 311 08$a0470722193 320 $aIncludes bibliographical references and index. 327 $apt. 1. Protein metabolism in liver disease -- pt. 2. The tiology of hepatic cirrhosis -- pt. 3. tiology of portal hypertension and ascites, and its treatment -- pt. 4. Pigment metabolism -- pt. 5. Splanching blood flow -- pt. 6. Infectious aspects of liver disease. 330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 410 0$aNovartis Foundation Symposia 517 3 $aLiver disease 606 $aLiver$xDiseases 615 0$aLiver$xDiseases. 676 $a616.3/62 701 $aSherlock$b Sheila$cDame.$0101649 701 $aWolstenholme$b G. E. W$g(Gordon Ethelbert Ward)$063039 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911018954203321 996 $aA Ciba Foundation symposium$93005128 997 $aUNINA